Nilsine Partners LLC Buys 595 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Nilsine Partners LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 9.5% during the fourth quarter, HoldingsChannel reports. The firm owned 6,889 shares of the medical equipment provider’s stock after purchasing an additional 595 shares during the quarter. Nilsine Partners LLC’s holdings in Intuitive Surgical were worth $3,596,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of ISRG. AQR Capital Management LLC lifted its stake in shares of Intuitive Surgical by 12.6% in the 2nd quarter. AQR Capital Management LLC now owns 42,691 shares of the medical equipment provider’s stock valued at $18,958,000 after purchasing an additional 4,775 shares during the period. Creative Planning lifted its position in Intuitive Surgical by 9.8% during the second quarter. Creative Planning now owns 63,039 shares of the medical equipment provider’s stock valued at $28,043,000 after buying an additional 5,629 shares during the period. NewEdge Advisors LLC boosted its holdings in shares of Intuitive Surgical by 8.2% during the 2nd quarter. NewEdge Advisors LLC now owns 13,825 shares of the medical equipment provider’s stock valued at $6,150,000 after buying an additional 1,044 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its position in shares of Intuitive Surgical by 2.1% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 20,458 shares of the medical equipment provider’s stock worth $9,100,000 after buying an additional 411 shares during the period. Finally, Wellington Wealth Strategies LLC. bought a new position in shares of Intuitive Surgical in the 2nd quarter worth about $241,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on ISRG shares. JPMorgan Chase & Co. upped their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. BTIG Research raised their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Finally, CICC Research started coverage on Intuitive Surgical in a report on Monday. They set a “neutral” rating and a $550.00 price target on the stock. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Get Our Latest Analysis on Intuitive Surgical

Insiders Place Their Bets

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at $12,391,166.97. This represents a 42.84 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction on Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the transaction, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,597,425. The trade was a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 42,265 shares of company stock worth $21,964,281 in the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Trading Down 1.8 %

NASDAQ ISRG opened at $573.48 on Tuesday. The stock’s 50 day moving average is $547.16 and its 200 day moving average is $505.21. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a market cap of $204.26 billion, a PE ratio of 92.20, a P/E/G ratio of 5.19 and a beta of 1.39.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.